Red Yeast Rice
Also known as: Monascus purpureus, Monacolin K, RYR, Beni-koji, Hongqu
Effective Dosage
3-10 mg/day monacolin K (active compound)
What the Science Says
Red yeast rice is a fermented rice product containing monacolin K, a compound chemically identical to the prescription statin lovastatin. It works by inhibiting the same enzyme statins target to reduce cholesterol production in the liver. Clinical studies show it can reduce LDL cholesterol by roughly 25–34% compared to placebo over 6–8 weeks, particularly at doses of 10 mg/day of monacolin K, though one well-designed trial found no significant LDL reduction compared to placebo when tested head-to-head against a low-dose statin.
What It Doesn't Do
Not a proven replacement for prescription statins in high-risk patients. Won't significantly lower triglycerides or raise HDL based on available data. Not proven to reduce actual heart attack or stroke risk in the short term. Not a 'natural' and automatically safe alternative — it carries the same muscle and liver risks as statins. Label claims about monacolin K content are often unreliable.
Evidence-Based Benefits
Red yeast rice contains monacolin K, a statin-like compound that inhibits HMG-CoA reductase and can reduce LDL-C by up to 34% and total cholesterol significantly compared to placebo (PMID: 40881894). Clinical trials show meaningful reductions in LDL-C, total cholesterol, and non-HDL-C in patients with mild-to-moderate dyslipidemia, particularly when combined with other nutraceuticals (PMID: 37836525, PMID: 37375586). However, one well-designed head-to-head trial found that red yeast rice as a standalone supplement did NOT significantly reduce LDL-C compared to placebo over 28 days, while rosuvastatin 5 mg reduced LDL-C by 35.2% (PMID: 36351465).
Moderate EvidenceEffective at: 3-10 mg/day monacolin K based on study doses
Source: auto-research
Absorption & Bioavailability
Unknown from provided studies; monacolin K is absorbed similarly to lovastatin, but actual content in supplements varies dramatically due to poor product standardization
Red Flags to Watch For
- Monacolin K is chemically identical to the prescription drug lovastatin — it carries the same risk of muscle damage (myopathy) and liver toxicity as statins
- Product quality is highly inconsistent: studies show wide variability in actual monacolin K content versus label claims, and some products contain undeclared pharmaceutical statins
- Contamination risk is real: a 2024 outbreak in Japan linked specific red yeast rice supplements (Beni-koji) to kidney injury in over 2,600 people, caused by the mycotoxin puberulic acid
- Citrinin contamination — a nephrotoxic and potentially reproductive-toxic mycotoxin — has been detected at high rates in red yeast rice products in food surveillance programs
- The SPORT trial (published in JACC) found red yeast rice did NOT significantly reduce LDL compared to placebo over 28 days, raising questions about real-world product potency
- European Food Safety Authority (EFSA) has raised formal safety concerns about red yeast rice supplements
Products Containing Red Yeast Rice
See how Red Yeast Rice is used in these analyzed products:
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06